45 related articles for article (PubMed ID: 22021695)
1. Anaphylactic reaction associated with intravenous administration of folinic acid in a patient with colon cancer.
Katirtzoglou NA; Hotchkiss S; Gambaccini M; Kaley K; Syrigos KN; Saif MW
In Vivo; 2011; 25(6):995-6. PubMed ID: 22021695
[TBL] [Abstract][Full Text] [Related]
2. Anaphylactic shock secondary to intravenous administration of folinic acid: a first report.
Benchalal M; Yahchouchy-Chouillard E; Fouere S; Fingerhut A
Ann Oncol; 2002 Mar; 13(3):480-1. PubMed ID: 11996482
[TBL] [Abstract][Full Text] [Related]
3. Weekly 24-h infusion of high-dose 5-fluorouracil (5-FU) with folinic acid (FA) in adjuvant therapy of colon cancer.
Wein A; Riedel C; Brückl W; Kastl S; Reingruber B; Hohenberger W; Hahn EG
Z Gastroenterol; 2001 Feb; 39(2):153-6. PubMed ID: 11253506
[TBL] [Abstract][Full Text] [Related]
4. Hypersensitivity reaction caused by folinic acid administration: a case report and literature review.
Florit-Sureda M; Conde-Estévez D; Vidal J; Montagut C
J Chemother; 2016 Dec; 28(6):500-505. PubMed ID: 26042586
[TBL] [Abstract][Full Text] [Related]
5. Weekly regimen of 5-FU vs 5-FU + intermediate dose folinic acid in the treatment of advanced colorectal cancer.
Martoni A; Cricca A; Guaraldi M; Covizzi M; Farris A; Pannuti F
Anticancer Res; 1992; 12(3):607-12. PubMed ID: 1622115
[TBL] [Abstract][Full Text] [Related]
6. Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06.
Lembersky BC; Wieand HS; Petrelli NJ; O'Connell MJ; Colangelo LH; Smith RE; Seay TE; Giguere JK; Marshall ME; Jacobs AD; Colman LK; Soran A; Yothers G; Wolmark N
J Clin Oncol; 2006 May; 24(13):2059-64. PubMed ID: 16648506
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy of colon cancer: lymph node involvement without metastases.
Prescrire Int; 2006 Jun; 15(83):109-1. PubMed ID: 16764102
[TBL] [Abstract][Full Text] [Related]
9. [A case of intra-peritoneal recurrence of colon carcinoma that responded remarkably to combined therapy of low-dose leucovorin and 5-fluorouracil].
Yamamoto T; Inoue F; Mutoh T; Tatematsu H; Yamataka K; Sakurai T; Kawahara H
Gan To Kagaku Ryoho; 2001 Sep; 28(9):1291-4. PubMed ID: 11579643
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy for localised colon cancer. Fluorouracil + folinic acid for node-positive, non-metastatic disease.
Prescrire Int; 2011 Feb; 20(113):46-9. PubMed ID: 21488594
[TBL] [Abstract][Full Text] [Related]
11. Clinical studies of biochemical modulation of 5-fluorouracil by leucovorin in patients with advanced colorectal cancer by the North Central Cancer Treatment Group and Mayo Clinic.
O'Connell MJ; Klaassen DJ; Everson LK; Cullinan S; Wieand HS
NCI Monogr; 1987; (5):185-8. PubMed ID: 3501540
[TBL] [Abstract][Full Text] [Related]
12. [A case of advanced colon cancer with marked response to combination chemotherapy with 5-FU, low dose CDDP, and leucovorin].
Takayanagi N; Ikuta Y; Anakura T
Gan To Kagaku Ryoho; 1997 Feb; 24(3):357-60. PubMed ID: 9051140
[TBL] [Abstract][Full Text] [Related]
13. Methylenetetrahydrofolate reductase polymorphism (677 C>T) predicts long time to progression in metastatic colon cancer treated with 5-fluorouracil and folinic acid.
Castillo-Fernández O; Santibáñez M; Bauza A; Calderillo G; Castro C; Herrera R; Serrano A; Arrieta O; Herrera LA
Arch Med Res; 2010 Aug; 41(6):430-5. PubMed ID: 21044746
[TBL] [Abstract][Full Text] [Related]
14. Palliative second-line treatment with weekly high-dose 5-fluorouracil as 24-hour infusion and folinic acid (AIO) plus oxaliplatin after pre-treatment with the AIO-regimen in colorectal cancer (CRC).
Link K; Happich K; Schirner I; Jüngert B; Brückl V; Männlein G; Brückl WM; Merkel S; Göhl J; Hohenberger W; Hahn EG; Wein A
Anticancer Res; 2004; 24(1):385-91. PubMed ID: 15015625
[TBL] [Abstract][Full Text] [Related]
15. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.
Haller DG; Catalano PJ; Macdonald JS; O'Rourke MA; Frontiera MS; Jackson DV; Mayer RJ
J Clin Oncol; 2005 Dec; 23(34):8671-8. PubMed ID: 16314627
[TBL] [Abstract][Full Text] [Related]
16. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of rectocolic and gastric adenocarcinomas with 5-fluorouracil associated with high doses of folinic acid. Results of an experimental study].
Machover D; Schwarzenberg L; Goldschmidt E; Tourani JM; Michalski B; Hayat M; Dorval T; Misset JL; Delouche C; Brochon D; Fraioli JP; Jasmin C; Maral R; Mathe G
Sem Hop; 1982 Sep; 58(33):1873-5. PubMed ID: 6293063
[TBL] [Abstract][Full Text] [Related]
19. Anaphylactic reaction to orthoiodohippurate.
Støckel M; Ennow K; Kristensen K; Rødbro P
Eur J Nucl Med; 1983; 8(2):89-90. PubMed ID: 6840130
[TBL] [Abstract][Full Text] [Related]
20. Hemocoagulase agkistrodon-induced anaphylactic shock: A case report and literature review.
Xu YY; Ma XH; Zhang SJ
Int J Clin Pharmacol Ther; 2016 Feb; 54(2):129-34. PubMed ID: 26636421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
